Aiforia Technologies Plc
FI-MF-000008986 · Finland · Helsinki
Aiforia Technologies Plc is registered in the European database on medical devices as a manufacturer, with 17 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
Devices declared under this manufacturer
- Aiforia® Breast Cancer Grading
- Aiforia® Clinical AI Model for Breast Cancer - HER2
- Aiforia® Clinical AI Model for Breast Cancer; ER
- Aiforia® Clinical AI Model for Breast Cancer; Ki67
- Aiforia® Clinical AI Model for Breast Cancer; PR
- Aiforia® Clinical AI Model for Lung Cancer; PD-L1
- Aiforia® Clinical AI Model for Prostate Cancer; Gleason Grade Groups
- Aiforia® Clinical Suite Viewer
- Aiforia® Gastric Cancer
- Aiforia® Lymph Node Metastasis
- Aiforia® Prostate Cancer Biopsy
- Aiforia® Prostate Cancer G4 Cribriform
Showing 12 of 17 declared devices.
Catalogue references include Aiforia® Breast Cancer Grading, Aiforia® Clinical AI Model for Breast Cancer - HER2, Aiforia® Clinical AI Model for Breast Cancer; Ki67, Aiforia® Clinical AI Model for Breast Cancer; PR, Aiforia® Clinical Suite Viewer, Aiforia® Gastric Cancer.
European nomenclature codes declared: W0202050392.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 17 |
| Country of registration | Finland |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 17 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. Aiforia Technologies Plc was not found in either the U.S. or the Canadian register.